Sequenom said this week that Ron Lindsay, the firm's executive VP of strategic planning, will retire from the company at the end of 2013, although he will continue to serve as a member of the firm's board of directors. Lindsay began working part-time for the firm in August.
Clay Patterson, managing director of Cerner Capital, has joined the board of directors at Claritas Genomics as part of an agreement between the two companies that included an investment by Cerner into Claritas.